Basal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Basal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma [Phase 2]
Phase 2 trial update for tirbanubulin (Klisiry) in basal cell carcinoma is reported, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma [Phase 3]
A Phase 3 clinical trial update evaluating intralesional 5-fluorouracil for basal cell carcinoma is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery [Phase 2]
Phase 2 clinical trial update for an artificial human skin product in basal cell carcinoma patients undergoing reconstructive surgery.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients [Phase 2]
Phase 2 clinical trial update for intratumoral administration of Daromun in basal cell carcinoma and cutaneous squamous cell carcinoma (non-…
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: L19IL2/L19TNF in Skin Cancer Patients [Phase 2]
Phase 2 clinical trial update for L19IL2/L19TNF in skin cancer patients with various skin cancers; status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage [Phase 4]
Phase 4 trial evaluating imiquimod 5% cream as adjuvant treatment after curettage for nodular basal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating 0.05% Ingenol Mebutate (Picato 500) for treatment of basal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers [Phase 1]
Phase 1 trial evaluating the combination of tacrolimus with immune checkpoint inhibitors nivolumab and ipilimumab in kidney transplant recip…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) [Phase 1, Phase 2]
Clinical trial update involving placebo microneedles in healthy volunteers (Part I) and efficacy/safety of doxorubicin microneedles in basal…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial [Phase 2]
Pilot phase 2 trial evaluating nicotinamide for prevention of skin cancer in transplant recipients.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma [Phase 3]
Phase 3 trial update for Metvix PDT in high-risk basal cell carcinoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: CellFX Treat & Resect Low-Risk BCC Feasibility Study [NA]
Feasibility study update for CellFX treatment and resection in low-risk basal cell carcinoma completed with posted results in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment [Phase 2]
A Phase 2 clinical trial is investigating the efficacy of 30% hydrogen peroxide topical application before definitive treatment for skin can…
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1 [Phase 4]
Phase 4 trial update examining how pharmacokinetics relate to safety signals for vismodegib in basal cell carcinoma patients.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) [Phase 1]
A Phase 1 dose-escalation trial of microneedle arrays delivering doxorubicin for basal cell carcinoma was terminated; results were posted in…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Tailored Sonidegib Schedule After Complete Response in BCC [Phase 2]
Phase 2 trial update exploring a tailored sonidegib schedule after complete response in locally advanced basal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy [Phase 2]
Phase 2 study evaluating a PD-1 inhibitor in patients with advanced basal cell carcinoma who progressed on Hedgehog pathway inhibitors or we…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating topical laser-assisted combination chemotherapy for basal cell carcinoma has completed enrollment with…
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Aldara for the Treatment of Large and/or Multiple sBCC [Phase 3]
A Phase 3 trial evaluating Aldara for large or multiple superficial basal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma [Phase 2]
A Phase 2 neoadjuvant study evaluating vismodegib in patients with large and/or recurrent resectable basal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma [Phase 3]
Phase 3 trial update evaluating the effectiveness of Imiquimod 5% cream in superficial basal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: VISmodegib for ORbital and Periocular Basal Cell Carcinoma [Phase 4]
Phase 4 clinical trial update for VISmodegib in orbital and periocular basal cell carcinoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study [Phase 3]
Phase 3 proof-of-concept trial exploring calcium electroporation for basal cell carcinoma (captioned as a proof-of-concept study; current st…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma [Phase 2]
A phase 2 trial evaluating IO103 with Montanide adjuvant for basal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Pilot Study of PDL to Treat BCC and SCCIS [NA]
Pilot study update for PDL in treating Basal Cell Carcinoma and Squamous Cell Carcinoma in Situ; study completed with results posted in 2019…